Screener
Immix Biopharma, Inc. IMMX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | - | |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 53,084,455 shares issued and 53,012,092 shares outstanding at March 31, 2026 and 53,023,466 shares issued and 52,951,103 shares outstanding at December 31, 2025 | 5,307 | 5,301 |
| Additional paid-in capital | 198,903,047 | 198,293,956 |
| Accumulated other comprehensive income | 105,636 | 60,160 |
| Accumulated deficit | (114,549,971) | (104,463,284) |
| Treasury stock at cost, 72,363 shares as of March 31, 2026 and December 31, 2025 | (99,963) | (99,963) |
| Total stockholders’ equity | 84,364,056 | 93,796,170 |
| Total liabilities and stockholders’ equity | $95,816,057 | $104,840,341 |
Document
FAQ
- What is Immix Biopharma, Inc.'s retained earnings?
- Immix Biopharma, Inc. (IMMX) reported retained earnings of -$114.55M in Q1 2026.
- How has Immix Biopharma, Inc.'s retained earnings changed year-over-year?
- Immix Biopharma, Inc.'s retained earnings decreased by 44.0% year-over-year, from -$79.57M to -$114.55M.
- What is the long-term trend for Immix Biopharma, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s retained earnings has grown at a 81.0% compound annual growth rate (CAGR), from -$5.37M to -$104.46M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Immix Biopharma, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude